This is the first study evaluating contextually both DPP4 concentration and activity, as well as the DPP4 mRNA expression in liver samples, in relation to the presence of biopsy-proven NAFLD/NASH. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.